• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

Recent Advances in the Study of D-Histidine Methyl Ester Dihydrochloride (CAS: 5714-80-7)

D-Histidine Methyl Ester Dihydrochloride (CAS: 5714-80-7) is a derivative of the amino acid histidine, which has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and biochemical studies. Recent studies have focused on its synthesis, characterization, and biological activities, shedding light on its utility as a building block for peptide synthesis and its role in modulating biological pathways.

One of the key advancements in the study of D-Histidine Methyl Ester Dihydrochloride is its improved synthetic methodology. Researchers have developed more efficient and scalable routes for its production, ensuring higher purity and yield. These advancements are critical for its application in large-scale pharmaceutical manufacturing. Additionally, the compound's stability under various physiological conditions has been investigated, providing insights into its potential as a drug candidate or a diagnostic tool.

In terms of biological activity, recent studies have explored the interaction of D-Histidine Methyl Ester Dihydrochloride with various enzymes and receptors. For instance, it has been shown to exhibit inhibitory effects on certain metalloproteinases, which are implicated in inflammatory diseases and cancer progression. These findings suggest its potential as a therapeutic agent for conditions characterized by excessive extracellular matrix degradation.

Furthermore, the compound's role in peptide synthesis has been a focal point of recent research. Its incorporation into peptide sequences has been demonstrated to enhance the stability and bioavailability of the resulting peptides, making it a valuable tool in the development of peptide-based therapeutics. This is particularly relevant in the context of targeted drug delivery systems, where peptide stability is paramount.

Another area of interest is the use of D-Histidine Methyl Ester Dihydrochloride in diagnostic applications. Its unique chemical properties make it suitable for use as a labeling agent in imaging studies, enabling researchers to track biological processes in real-time. This has potential implications for the early detection and monitoring of diseases such as cancer and neurodegenerative disorders.

In conclusion, the recent research on D-Histidine Methyl Ester Dihydrochloride (CAS: 5714-80-7) highlights its multifaceted applications in chemical biology and pharmaceutical sciences. From its role in peptide synthesis to its potential as a therapeutic and diagnostic agent, this compound continues to be a subject of intense investigation. Future studies are expected to further elucidate its mechanisms of action and expand its utility in medical and biochemical applications.

• 2485-62-3(methyl (2R)-2-amino-3-sulfanylpropanoate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)